Gitit Tomer
<p><span><span>Dr. Tomer is the director of the Pediatric Inflammatory Bowel Disease program at the Children's Hospital at Montefiore. </span></span>She is Associate Professor of Clinical Pediatrics. Dr. Tomer graduated from Sackler School of Medicine, Tel- Aviv, Israel. Dr. Tomer completed her Pediatric Residency at New York University School of Medicine and her Pediatric Gastroenterogy and Nutrition Fellowship at Mount Sinai Medical Center, New York. Dr Tomer was Assistant Professor of Pediatrics in the Division of Pediatric Gastroenterology at Cincinnati Children’s Hospital for four years prior to joining the Pediatric GI Division at The Children’s Hospital at Montefiore in 2009. Dr. Tomer’s research interests include inflammatory bowel diseases, quality improvement work, and capsule endoscopy. </p>
<p>1. Obtaining research biopsies during pediatric colonoscopy: Safety and adverse events. Mait-Kaufman J, Kahn S, Tomer G. World J Gastrointest Endosc. 2015 Jun 25;7(7):736-40. doi: 10.4253/wjge.v7.i7.736.</p>
<p>2. Improving Nonattendance at Outpatient Pediatric Endoscopy Unit of a Tertiary Center. Kogan-Liberman D, Rivas Y, Thompson J, Tomer G. J Pediatr Gastroenterol Nutr. 2015 Aug;61(2):234-7. doi: 10.1097/MPG.0000000000000791.</p>
<p>3. Improving the timeliness of procedures in a pediatric endoscopy suite. Tomer G, Choi S, Montalvo A, Sutton S, Thompson J, Rivas Y. Pediatrics. 2014 Feb;133(2):e428-33. doi: 10.1542/peds.2013-2316. Epub 2014 Jan 20.</p>
<p>4. Improved outcomes with quality improvement interventions in pediatric inflammatory bowel disease. Samson CM, Morgan P, Williams E, Beck L, Addie-Carson R, McIntire S, Booth A, Mendez E, Luzader C, Tomer G, Saeed S, Donovan E, Bucuvalas J, Denson LA. J Pediatr Gastroenterol Nutr. 2012 Dec;55(6):679-88. doi: 10.1097/MPG.0b013e318262de16.</p>
<p>5.Factors that determine risk for surgery in pediatric patients with Crohn's disease. Schaefer ME, Machan JT, Kawatu D, Langton CR, Markowitz J, Crandall W, Mack DR, Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo DJ, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-Hemker M, Kappelman MD, Saeed SA, Hyams JS, Leleiko NS. Clin Gastroenterol Hepatol. 2010 Sep;8(9):789-94. doi: 10.1016/j.cgh.2010.05.021. Epub 2010 May 31.</p>
<p> 6. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. Dotson JL, Hyams JS, Markowitz J, LeLeiko NS, Mack DR, Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo D, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-Hemker M, Langton CR, Crandall W. J Pediatr Gastroenterol Nutr. 2010 Aug;51(2):140-5. doi: 10.1097/MPG.0b013e3181ca4db4.</p>
<p>7. Outcome following infliximab therapy in children with ulcerative colitis. Hyams JS, Lerer T, Griffiths A, Pfefferkorn M, Stephens M, Evans J, Otley A, Carvalho R, Mack D, Bousvaros A, Rosh J, Grossman A, Tomer G, Kay M, Crandall W, Oliva-Hemker M, Keljo D, LeLeiko N, Markowitz J; Pediatric Inflammatory Bowel Disease Collaborative Research Group. Am J Gastroenterol. 2010 Jun;105(6):1430-6. doi: 10.1038/ajg.2009.759. Epub 2010 Jan 26.</p>
<p> 8. Polymorphisms in the IBD5 locus are associated with Crohn disease in pediatric Ashkenazi Jewish patients. Tomer G, Wetzler G, Keddache M, Denson LA. J Pediatr Gastroenterol Nutr. 2009 May;48(5):531-7. doi: 10.1097/MPG.0b013e318183138a.</p>
<p>9. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease. Han X, Uchida K, Jurickova I, Koch D, Willson T, Samson C, Bonkowski E, Trauernicht A, Kim MO,Tomer G, Dubinsky M, Plevy S, Kugathsan S, Trapnell BC, Denson LA. Gastroenterology. 2009 Apr;136(4):1261-71, e1-3. doi: 10.1053/j.gastro.2008.12.046. Epub 2008 Dec 24.</p>
<p>10. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Kugathasan S, Baldassano RN, Bradfield JP, Sleiman PM, Imielinski M, Guthery SL, Cucchiara S, Kim CE, Frackelton EC, Annaiah K, Glessner JT, Santa E, Willson T, Eckert AW, Bonkowski E, Shaner JL, Smith RM, Otieno FG, Peterson N, Abrams DJ, Chiavacci RM, Grundmeier R, Mamula P,Tomer G, Piccoli DA, Monos DS, Annese V, Denson LA, Grant SF, Hakonarson H. Nat Genet. 2008 Oct;40(10):1211-5. doi: 10.1038/ng.203. Epub 2008 Aug 31.</p>
<p> 11. Genetic variants in the autophagy pathway contribute to paediatric Crohn's disease. Peterson N, Guthery S, Denson L, Lee J, Saeed S, Prahalad S, Biank V, Ehlert R, Tomer G, Grand R, Rudolph C, Kugathasan S. Gut. 2008 Sep;57(9):1336-7; author reply 1337. doi: 10.1136/gut.2008.152207. No abstract available.</p>
<p> 12. Electronic clinical challenges and images in GI. Meckel's diverticulum. Zeisler B, Moyer SM, Farrell M, Collins MH, Tomer G. Gastroenterology. 2008 Apr;134(4):e3-4. doi: 10.1053/j.gastro.2008.02.039. No abstract available. Erratum in: Gastroenterology. 2008 Jul;135(1):326.</p>
<p>13.NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease. Tomer G, Ceballos C, Concepcion E, Benkov KJ. Am J Gastroenterol. 2003 Nov;98(11):2479-84.</p>
<p>14. Disorders of bile formation and biliary transport. Tomer G, Shneider BL. Gastroenterol Clin North Am. 2003 Sep;32(3):839-55, vi. Review.</p>
<p>15. Differential developmental regulation of rat liver canalicular membrane transporters Bsep and Mrp2. Tomer G, Ananthanarayanan M, Weymann A, Balasubramanian N, Suchy FJ. Pediatr Res. 2003 Feb;53(2):288-94.</p>
<p> </p>
<p> </p>
<p>Gitit Tomer, MD, is Director of the Pediatric Inflammatory Bowel Disease (IBD) Program at Children’s Hospital at Montefiore (CHAM) and Professor of Pediatrics at our Albert Einstein College of Medicine. Dr. Tomer has been a member of the Montefiore team since 2009, with a clinical focus on inflammatory bowel disease, performance improvement and capsule endoscopy.</p><p>Dr. Tomer received her medical degree from Sackler School of Medicine, Tel-Aviv University, in 1995. She completed her Pediatric internship and residency at New York University School of Medicine in 1998, and went on to complete her Pediatric Gastroenterology and Nutrition fellowship at Mount Sinai Medical Center in 2001.</p><p>Dr. Tomer’s focus on IBD, performance improvement and endoscopy extend to her research interests. She is the CHAM physician leader of ImproveCareNow, a national collaborative that champions improved care for children and youth with Crohn’s disease and ulcerative colitis. Her research in pediatric IBD examines many facets, extending from the racial differences in initial presentation, early treatment and 1-year outcomes in pediatric Crohn’s disease, to differences in satisfaction with work-life balance among pediatric gastroenterologists. Dr. Tomer’s work has been published in a number of reviewed journals, books, review articles, and abstracts.</p><p>Dr. Tomer is board certified by the American Board of Pediatrics in Pediatric Gastroenterology. She is a member of the American Gastroenterological Association (AGA) and the Crohn's & Colitis Foundation of America (CCFA), and serves as the chair of the Professional Development Committee of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).</p>